Global Normal Bovine Calf Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Normal Bovine Calf Serum Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bovine Calf Serum (BCS) is collected from calves that are less than 12 months old. The serum contains approximately double the protein of fetal bovine serum (FBS). BCS will promote growth in a variety of mammalian cell lines and is often used as a cost-effective substitute for FBS.
Normal Bovine Calf Serum report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Normal Bovine Calf Serum market is projected to reach US$ 855.6 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Scientific Research and Industrial Production are the major drivers for the industry.
The bovine calf serum market is primarily driven by the increasing demand from various industries, including biotechnology, pharmaceuticals, and research laboratories. Bovine calf serum is a vital component in cell culture media, supporting cell growth and promoting cell proliferation in these industries' applications. The rising adoption of cell culture techniques in drug development, vaccine production, and other biotechnological processes has significantly contributed to the market's growth. Additionally, the surging demand for regenerative medicine and stem cell research further fuels the need for bovine calf serum. However, the market faces challenges related to ethical concerns over animal-derived products and the risk of transmitting infectious agents. Stringent regulations and efforts towards developing serum-free alternatives also pose obstacles to the market's expansion. To sustain growth, the industry must address these challenges and invest in research for safe and ethical alternatives while meeting the increasing demand for bovine calf serum.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Normal Bovine Calf Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher
Merck
Corning
Cytiva
Biowest
Bovogen
Moregate Biotech
Gemini
Sartorius (Bioind)
Animal Technologies
Tissue Culture Biologicals
Internegocios
Minhai Bio
Xinuo Bio
Wuhan Sanli
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Scientific Research
Industrial Production
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Normal Bovine Calf Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Normal Bovine Calf Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Normal Bovine Calf Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Normal Bovine Calf Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Normal Bovine Calf Serum introduction, etc. Normal Bovine Calf Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Normal Bovine Calf Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Normal Bovine Calf Serum report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Normal Bovine Calf Serum market is projected to reach US$ 855.6 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Scientific Research and Industrial Production are the major drivers for the industry.
The bovine calf serum market is primarily driven by the increasing demand from various industries, including biotechnology, pharmaceuticals, and research laboratories. Bovine calf serum is a vital component in cell culture media, supporting cell growth and promoting cell proliferation in these industries' applications. The rising adoption of cell culture techniques in drug development, vaccine production, and other biotechnological processes has significantly contributed to the market's growth. Additionally, the surging demand for regenerative medicine and stem cell research further fuels the need for bovine calf serum. However, the market faces challenges related to ethical concerns over animal-derived products and the risk of transmitting infectious agents. Stringent regulations and efforts towards developing serum-free alternatives also pose obstacles to the market's expansion. To sustain growth, the industry must address these challenges and invest in research for safe and ethical alternatives while meeting the increasing demand for bovine calf serum.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Normal Bovine Calf Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Merck
Corning
Cytiva
Biowest
Bovogen
Moregate Biotech
Gemini
Sartorius (Bioind)
Animal Technologies
Tissue Culture Biologicals
Internegocios
Minhai Bio
Xinuo Bio
Wuhan Sanli
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Scientific Research
Industrial Production
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Normal Bovine Calf Serum market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Normal Bovine Calf Serum, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Normal Bovine Calf Serum industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Normal Bovine Calf Serum in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Normal Bovine Calf Serum introduction, etc. Normal Bovine Calf Serum Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Normal Bovine Calf Serum market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices